Generalized concentration addition: a method for examining mixtures containing partial agonists.
暂无分享,去创建一个
[1] W. Greco,et al. The search for synergy: a critical review from a response surface perspective. , 1995, Pharmacological reviews.
[2] U. Kristiansen,et al. Irritation of the upper airways from mixtures of cumene and n-propanol. Mechanisms and their consequences for setting industrial exposure limits. , 1988 .
[3] D. Jenkinson,et al. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology. , 1995, Pharmacological reviews.
[4] Nelly van der Hoeven,et al. Current issues in statistics and models for ecotoxicological risk assessment. , 2004 .
[5] J. V. van Rossum,et al. A theoretical basis of molecular pharmacology. I. Interactions of one or two compounds with one receptor system. , 1956, Arzneimittel-Forschung.
[6] A. Brouwer,et al. Species-specific antagonism of Ah receptor action by 2,2',5,5'-tetrachlorobiphenyl. , 1993 .
[7] C. I. Bliss. THE TOXICITY OF POISONS APPLIED JOINTLY1 , 1939 .
[8] Terrence P. Kenakin,et al. A Pharmacologic Analysis of Drug-Receptor Interaction , 1987 .
[9] T. Kenakin,et al. The ligand paradox between affinity and efficacy: can you be there and not make a difference? , 2002, Trends in pharmacological sciences.
[10] Joseph R. DiPalma,et al. Principles of Drug Action: The Basis of Pharmacology , 1968 .
[11] E. J. Ariëns. Molecular pharmacolōgy : the mode of action of biologically active compounds , 1964 .
[12] C. Tohyama,et al. The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[13] Nigel J Walker,et al. Evaluation of toxic equivalency factors for induction of cytochromes P450 CYP1A1 and CYP1A2 enzyme activity by dioxin-like compounds. , 2004, Toxicology and applied pharmacology.
[14] M. Berenbaum. What is synergy? , 1989, Pharmacological reviews.
[15] Paula Sánchez-Marín,et al. Comments on “Isobolographic Analysis for Combinations of a Full and Partial Agonist: Curved Isoboles” , 2006, Journal of Pharmacology and Experimental Therapeutics.
[16] E. L I S A B E T E S I L V A,et al. Something from “ Nothing ”-Eight Weak Estrogenic Chemicals Combined at Concentrations below NOECs Produce Significant Mixture Effects , 2022 .
[17] Ronald J. Tallarida. Response to Comments on “Isobolographic Analysis for Combinations of a Full and Partial Agonist: Curved Isoboles” , 2006, Journal of Pharmacology and Experimental Therapeutics.
[18] Ariens Ej,et al. A theoretical basis of molecular pharmacology. I. Interactions of one or two compounds with one receptor system. , 1956 .
[19] Kannan Krishnan,et al. Physiological modeling and extrapolation of pharmacokinetic interactions from binary to more complex chemical mixtures. , 2002, Environmental health perspectives.
[20] J. Foreman,et al. Textbook of Receptor Pharmacology , 2011 .
[21] M. E. Hahn,et al. Relative contributions of affinity and intrinsic efficacy to aryl hydrocarbon receptor ligand potency. , 2000, Toxicology and applied pharmacology.
[22] J. Black,et al. Operational models of pharmacological agonism , 1983, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[23] John P. Groten,et al. Sensory irritation to mixtures of formaldehyde, acrolein, and acetaldehyde in rats , 1996, Archives of Toxicology.
[24] Eric B Higley,et al. Relative potencies of individual chlorinated and brominated polycyclic aromatic hydrocarbons for induction of aryl hydrocarbon receptor-mediated responses. , 2009, Environmental science & technology.
[25] Limitations of the toxic equivalency factor approach for risk assessment of TCDD and related compounds. , 1997, Teratogenesis, carcinogenesis, and mutagenesis.
[26] Berenbaum Mc. What is synergy? , 1989, Pharmacological reviews.